Fibersol®, a digestion-resistant soluble dietary fiber backed by over 30 years of extensive clinical research, may support ...

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and ...

Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Peptide APIs are manufactured via a series of chemical reactions assembling a chain from monomeric components. The most common synthesis routes consist of either solid-phase peptide synthesis ...

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

GLP-1 is a hormone naturally produced by the body that plays a key role in appetite regulation, blood sugar control, and ...

Analogues of the natural glucagon-mimetic Glucagon-Like Peptide-1 (GLP-1) reduce body mass and help to prevent type-2 diabetes mellitus and cancer development, partly by inhibiting glycogen synthase ...